RNA, U6 small nuclear 1284, pseudogene (RNU6-1284P)

RNA, U6 small nuclear 1284, pseudogene (RNU6-1284P) is a non-protein coding pseudogene in the human genome, classified as a processed pseudogene of a U6 small nuclear RNA (snRNA) gene[1][3][5][8][9][11]. U6 snRNAs are normally essential components of the spliceosome, participating in pre-mRNA splicing, but RNU6-1284P lacks the ability to produce a functional snRNA due to sequence changes and is considered transcriptionally and functionally inactive[8][11]. Pseudogenes like RNU6-1284P commonly arise through reverse transcription and retrotransposition mechanisms, particularly mediated by LINE-1 (L1) elements, which can duplicate and insert snRNA sequences into new genomic locations without retaining their original function[2]. There are no known reports that this locus encodes a functional RNA or protein, nor is it considered a druggable or disease-relevant therapeutic target[3][5][8][11]. Summary of key points: - RNU6-1284P is best classified as a small nuclear RNA pseudogene. - It is not a receptor, enzyme, or other typical drug target. - No therapeutic, diagnostic, or clinical significance is attributed to RNU6-1284P. - No drugs or biomarker roles are known for this locus. - The gene is correctly named and officially recognized (HGNC:48247)[11]. - The only meaningful alias is its abbreviation, RNU6-1284P. - Pseudogenes like this are used mainly in evolutionary and genomic studies as markers of retrotransposition events[2].

Other names

RNU6-1284P